Atlas Venture Fund Xi, L.P. Insider Trades

Insider Trading History

Track insider trading activity for Atlas Venture Fund Xi, L.P.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Third Harmonic Bio
Third Harmonic Bio THRD
10% owner
Holding Value $52.7M 9,798,075 shares
Last Trade
Nov 01, 2024 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$7.39M 515,688 shares
$14.33
$5.38
Dyne Therapeutics
Dyne Therapeutics DYN
10% owner
Holding Value $115M 5,700,521 shares
Last Trade
Feb 28, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.74M 190,920 shares
$24.84
$20.26
Dyne Therapeutics
Dyne Therapeutics DYN
10% owner
Holding Value $119M 5,878,544 shares
Last Trade
Feb 27, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$9M 368,699 shares
$24.41
$20.26
Dyne Therapeutics
Dyne Therapeutics DYN
10% owner
Holding Value $126M 6,216,250 shares
Last Trade
Feb 26, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.89M 248,219 shares
$23.72
$20.26
Dyne Therapeutics
Dyne Therapeutics DYN
10% owner
Holding Value $129M 6,352,562 shares
Last Trade
Feb 23, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.47M 196,928 shares
$22.70
$20.26
Dyne Therapeutics
Dyne Therapeutics DYN
10% owner
Holding Value $132M 6,512,104 shares
Last Trade
Feb 22, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.7M 119,360 shares
$22.66
$20.26
Dyne Therapeutics
Dyne Therapeutics DYN
10% owner
Holding Value $135M 6,666,628 shares
Last Trade
Feb 21, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.16M 184,501 shares
$22.57
$20.26
Dyne Therapeutics
Dyne Therapeutics DYN
10% owner
Holding Value $138M 6,819,475 shares
Last Trade
Feb 20, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.85M 169,539 shares
$22.72
$20.26
Dyne Therapeutics
Dyne Therapeutics DYN
10% owner
Holding Value $142M 6,985,504 shares
Last Trade
Feb 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.77M 162,707 shares
$23.14
$20.26
Dyne Therapeutics
Dyne Therapeutics DYN
10% owner
Holding Value $145M 7,150,324 shares
Last Trade
Feb 15, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.25M 177,906 shares
$23.89
$20.26
Xilio Therapeutics
Xilio Therapeutics XLO
10% owner
Holding Value $18M 2,019,563 shares
Last Trade
Feb 08, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$640 1,000 shares
$0.64
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
10% owner
Holding Value $18M 2,020,296 shares
Last Trade
Jan 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.56k 2,100 shares
$0.74
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
10% owner
Holding Value $18M 2,021,836 shares
Last Trade
Jan 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.86k 2,135 shares
$0.87
$8.90
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
Director
Holding Value $129M 6,008,534 shares
Last Trade
Dec 12, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$12M 600,854 shares
$19.97
$21.53
Third Harmonic Bio
Third Harmonic Bio THRD
10% owner
Holding Value $0 0 shares
Last Trade
Sep 19, 2022 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$38.8M 2,282,537 shares
$17.00
$5.38
Third Harmonic Bio
Third Harmonic Bio THRD
10% owner
Holding Value $3.2M 594,096 shares
Last Trade
Sep 19, 2022 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$10.1M 594,096 shares
$17.00
$5.38
Third Harmonic Bio
Third Harmonic Bio THRD
10% owner
Holding Value $53.9M 10,013,763 shares
Last Trade
Sep 19, 2022 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$110M 6,472,374 shares
$17.00
$5.38
Day One Biopharmaceuticals
Day One Biopharmaceuticals DAWN
10% owner
Holding Value $142M 6,609,388 shares
Last Trade
Sep 19, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$12.3M 600,854 shares
$20.54
$21.53
Third Harmonic Bio
Third Harmonic Bio THRD
10% owner
Holding Value $0 0 shares
Last Trade
Sep 19, 2022 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$10.1M 594,096 shares
$17.00
$5.38
Third Harmonic Bio
Third Harmonic Bio THRD
10% owner
Holding Value $55.5M 10,313,763 shares
Last Trade
Sep 19, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.1M 300,000 shares
$17.00
$5.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up